Cavalier Investments, LLC Dexcom Inc Transaction History

Cavalier Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $155,376 - $208,164	-1,992 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $110,887 - $131,134	-1,161 Reduced 36.82%	1,992 $821,000
Q2 2020 Aug 10, 2020	BUY	$62.68 - $105.34 $78,538 - $131,991	1,253 Added 65.95%	3,153 $1.28 Million
Q1 2020 May 06, 2020	SELL	$47.79 - $75.63 $76,464 - $121,008	-1,600 Reduced 45.71%	1,900 $512,000
Q4 2018 Feb 01, 2019	BUY	$26.99 - $37.37 $94,465 - $130,794	3,500 New	3,500 $419,000

1,085

376M

6.76M

7.24M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $22.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cavalier Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Cavalier Investments, LLC with notifications on news.